Cookie policy

This site uses cookies to improve your user experience. By using this website, you agree that we can place cookies on your device. For further information, please read our Privacy And Cookies Policy

I accept the terms and conditions
Skip Ribbon Commands
Skip to main content

Interventional Cardiology

Products

Solutions

 

 

Mastering Rapid and Healthy Vascular Repairhttps://www.terumo-europe.com/en-emea/clinicaldata/mastering-rapid-and-healthy-vascular-repairMastering Rapid and Healthy Vascular RepairPushing the boundaries of science and medical engineering for the improvement of health: Ultimaster combines an optimal balance between stent design for ultimate conformability with simultaneous polymer resorption and drug release, to match the procedure-triggered biological response in the vessel.(1) This results in optimal vessel recovery and potentially shortened DAPT time.(2)HayabusaArticlePage
CENTURY II Trial highlightshttps://www.terumo-europe.com/en-emea/clinicaldata/century-iiCENTURY II Trial highlightsMulticentre, intercontinental study - 58 sites in 13 countries across Europe, Japan, and South Korea - Primary endpoint: Freedom from TLF at 9 months - Secondary endpoint: rate of TVF; patient-oriented composite endpoint; rate of TLR, TVR, ST, cardiac death, MI; composite of cardiac death and MI; rate of bleeding and vascular complications - Clinical follow-up up to 5 years HayabusaArticlePage
DISCOVERY 1TO3 Trialhttps://www.terumo-europe.com/en-emea/clinicaldata/discovery-1to3-trialDISCOVERY 1TO3 Trial60 MVD patients with OFDI, single arm, primary endpoint TLF @ 12M. Ongoing.HayabusaArticlePage

 

 

 

 

 

 

Terumo to Launch the Ultimaster Tansei Drug Eluting Stent in Europehttps://www.terumo-europe.com/en-emea/news/terumo-to-launch-the-ultimaster-tansei-drug-eluting-stent-in-europeTerumo to Launch the Ultimaster Tansei Drug Eluting Stent in EuropeTokyo, Japan23/05/2018 22:00:00
Terumo receives CE Mark for Ultimaster TANSEI drug-eluting stenthttps://www.terumo-europe.com/en-emea/news/terumo-receives-ce-mark-for-ultimaster-tansei-drug-eluting-stentTerumo receives CE Mark for Ultimaster TANSEI drug-eluting stentLeuven, Belgium22/04/2018 22:00:00
Terumo Provides Update on Impact from Hurricane Mariahttps://www.terumo-europe.com/en-emea/news/terumo-provides-update-on-impact-from-hurricane-mariaTerumo Provides Update on Impact from Hurricane MariaTokyo, Japan12/10/2017 22:00:00

 

 

ESC 2018https://www.terumo-europe.com/en-emea/Events/ESC 2018.aspxESC 2018Germany24/08/2018 22:00:0029/08/2018 15:00:00Munichhttps://www.escardio.org/Congresses-%26-Events/ESC-Congress/About-the-congress/ESC-Congress-2018, https://www.escardio.org/Congresses-&-Events/ESC-Congress/About-the-congress/ESC-Congress-2018
Euro CTO Club 2018https://www.terumo-europe.com/en-emea/Events/Euro CTO Club 2018.aspxEuro CTO Club 2018France27/09/2018 22:00:0029/09/2018 15:02:00Toulousehttp://www.eurocto.eu/events.aspx, http://www.eurocto.eu/events.aspx